Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1856 1
1904 1
1918 1
1933 1
1936 1
1938 1
1941 1
1946 1
1947 1
1948 5
1949 2
1950 2
1951 2
1952 2
1954 1
1956 1
1957 1
1958 1
1959 1
1960 1
1962 3
1963 1
1964 1
1966 1
1967 1
1968 4
1970 5
1971 3
1972 4
1973 5
1974 1
1975 1
1976 6
1977 3
1978 4
1979 2
1980 6
1981 4
1982 4
1983 7
1984 9
1985 10
1986 10
1987 9
1988 9
1989 14
1990 7
1991 11
1992 15
1993 9
1994 12
1995 6
1996 11
1997 10
1998 11
1999 18
2000 22
2001 20
2002 17
2003 18
2004 19
2005 38
2006 32
2007 32
2008 36
2009 35
2010 40
2011 51
2012 49
2013 63
2014 71
2015 60
2016 59
2017 66
2018 59
2019 47
2020 64
2021 92
2022 64
2023 25

Text availability

Article attribute

Article type

Publication date

Search Results

1,183 results

Results by year

Filters applied: . Clear all
Page 1
Enterococci enhance Clostridioides difficile pathogenesis.
Smith AB, Jenior ML, Keenan O, Hart JL, Specker J, Abbas A, Rangel PC, Di C, Green J, Bustin KA, Gaddy JA, Nicholson MR, Laut C, Kelly BJ, Matthews ML, Evans DR, Van Tyne D, Furth EE, Papin JA, Bushman FD, Erlichman J, Baldassano RN, Silverman MA, Dunny GM, Prentice BM, Skaar EP, Zackular JP. Smith AB, et al. Nature. 2022 Nov;611(7937):780-786. doi: 10.1038/s41586-022-05438-x. Epub 2022 Nov 16. Nature. 2022. PMID: 36385534 Free PMC article.
Epidemiology, Screening, and Prevention of Bladder Cancer.
Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, Gupta S, Smith AB, Williams SB, Lotan Y. Lobo N, et al. Among authors: smith ab. Eur Urol Oncol. 2022 Dec;5(6):628-639. doi: 10.1016/j.euo.2022.10.003. Epub 2022 Nov 1. Eur Urol Oncol. 2022. PMID: 36333236 Review.
What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis.
Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WWT, Lebel S, Simard S, Smith AB, Zachariae R, Afiyanti Y, Bell KJL, Custers JAE, de Wit NJ, Fisher PL, Galica J, Garland SN, Helsper CW, Jeppesen MM, Liu J, Mititelu R, Monninkhof EM, Russell L, Savard J, Speckens AEM, van Helmondt SJ, Vatandoust S, Zdenkowski N, van der Lee ML. Luigjes-Huizer YL, et al. Among authors: smith ab. Psychooncology. 2022 Jun;31(6):879-892. doi: 10.1002/pon.5921. Epub 2022 Apr 7. Psychooncology. 2022. PMID: 35388525 Free PMC article. Review.
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
Rose TL, Harrison MR, Deal AM, Ramalingam S, Whang YE, Brower B, Dunn M, Osterman CK, Heiling HM, Bjurlin MA, Smith AB, Nielsen ME, Tan HJ, Wallen E, Woods ME, George D, Zhang T, Drier A, Kim WY, Milowsky MI. Rose TL, et al. Among authors: smith ab. J Clin Oncol. 2021 Oct 1;39(28):3140-3148. doi: 10.1200/JCO.21.01003. Epub 2021 Aug 24. J Clin Oncol. 2021. PMID: 34428076 Free PMC article. Clinical Trial.
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.
Rose TL, Weir WH, Mayhew GM, Shibata Y, Eulitt P, Uronis JM, Zhou M, Nielsen M, Smith AB, Woods M, Hayward MC, Salazar AH, Milowsky MI, Wobker SE, McGinty K, Millburn MV, Eisner JR, Kim WY. Rose TL, et al. Among authors: smith ab. Br J Cancer. 2021 Oct;125(9):1251-1260. doi: 10.1038/s41416-021-01488-6. Epub 2021 Jul 22. Br J Cancer. 2021. PMID: 34294892 Free PMC article.
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Kleinmann N, Matin SF, Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Adibi M, Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, Lerner SP. Kleinmann N, et al. Among authors: smith ab. Lancet Oncol. 2020 Jun;21(6):776-785. doi: 10.1016/S1470-2045(20)30147-9. Epub 2020 Apr 29. Lancet Oncol. 2020. PMID: 32631491 Clinical Trial.
AUTHOR REPLY.
Filippou P, Demzik A, Smith AB. Filippou P, et al. Among authors: smith ab. Urology. 2021 Apr;150:8. doi: 10.1016/j.urology.2020.08.070. Urology. 2021. PMID: 33812556 No abstract available.
AUTHOR REPLY.
Filippou P, Demzik A, Smith AB. Filippou P, et al. Among authors: smith ab. Urology. 2021 Apr;150:8. doi: 10.1016/j.urology.2020.08.068. Urology. 2021. PMID: 33812555 No abstract available.
EDITORIAL COMMENT.
Talwar R, Smith AB. Talwar R, et al. Among authors: smith ab. Urology. 2021 Apr;150:58. doi: 10.1016/j.urology.2020.04.137. Urology. 2021. PMID: 33812548 No abstract available.
1,183 results